![Figure 5 from Oncological and functional outcome of intersphincteric resection and coloanal anastomosis for very low rectal cancer | Semantic Scholar Figure 5 from Oncological and functional outcome of intersphincteric resection and coloanal anastomosis for very low rectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72699c60cead2e6fe4c8217981e22cd357452315/25-Table2-1.png)
Figure 5 from Oncological and functional outcome of intersphincteric resection and coloanal anastomosis for very low rectal cancer | Semantic Scholar
![ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making - Annals of Oncology ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/82048ebc-28d3-4651-87d3-6759a8af3274/gr1.jpg)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making - Annals of Oncology
![Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk | World Journal of Surgical Oncology | Full Text Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-019-1763-9/MediaObjects/12957_2019_1763_Fig1_HTML.png)
Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk | World Journal of Surgical Oncology | Full Text
![The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon | British Journal of Cancer The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01470-2/MediaObjects/41416_2021_1470_Fig1_HTML.png)
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon | British Journal of Cancer
![Rectal Carcinoma Imaging: Practice Essentials, Screening Guidelines, Staging and Surveillance Guidelines Rectal Carcinoma Imaging: Practice Essentials, Screening Guidelines, Staging and Surveillance Guidelines](https://img.medscapestatic.com/pi/meds/ckb/34/18134tn.jpg)
Rectal Carcinoma Imaging: Practice Essentials, Screening Guidelines, Staging and Surveillance Guidelines
![Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/91b95b84-b5b6-4d86-8fac-491f80014725/gr4.jpg)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Frontiers | Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West? Frontiers | Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?](https://www.frontiersin.org/files/Articles/497475/fsurg-06-00079-HTML-r2/image_m/fsurg-06-00079-g001.jpg)